Pegis J D, Papon X, Pasco A, Regnard O, Abraham P, Enon B
Service de Chirurgie Cardio-Vasculaire et Thoracique, CHRU Angers.
J Mal Vasc. 1997 Jul;22(3):187-92.
From March 1989 to March 1993, six athletic patients were treated in our institution by thrombolytic therapy for acute effort axillary-subclavian vein thrombosis in thoracic outlet syndrome. Mean age of these patients was 20 (range 14 to 27). An in situ infusion with urokinase (2,500 U/kg/h) and Heparin (100 U/kg/12 hours) was given during 64 hours (Range 14 to 72). Phlebography showed a complete reperfusion in three cases (the treatment began within an average period of 5.6 days), partial reperfusion in two cases (the treatment began within an average period of 8.5 days). In one case there was no reperfusion on phlebography: treatment began within an average period of 15 days. For this patient, a venous axillo-jugular bypass graft was performed. In all cases, there was no bleeding complication. A trans-axillary first rib resection was done three months later. Mean follow up was 31 months (range: two to 51 months). All patients recovered their previous physical status. Echo-Doppler exam showed normal subclavian vein flow in four cases, partial occlusion in one case and a total occlusion of the subclavian vein flow in one case. In this last case, the thrombolytic therapy failed to restore the permeability of the subclavian vein. Bypassgraft was patent. Axillary-subclavian vein thrombosis seen within a period of seven days should be treated by local thrombolytic therapy using urokinase and heparin.
1989年3月至1993年3月,我院对6例患有胸廓出口综合征且因剧烈活动导致急性腋-锁骨下静脉血栓形成的运动员患者进行了溶栓治疗。这些患者的平均年龄为20岁(范围14至27岁)。在64小时(范围14至72小时)内进行了尿激酶(2500 U/kg/h)和肝素(100 U/kg/12小时)的原位输注。静脉造影显示3例完全再通(治疗平均在5.6天内开始),2例部分再通(治疗平均在8.5天内开始)。1例静脉造影未显示再通:治疗平均在15天内开始。对该患者进行了腋-颈静脉搭桥移植术。所有病例均无出血并发症。三个月后进行了经腋第一肋切除术。平均随访31个月(范围:2至51个月)。所有患者均恢复了之前的身体状况。超声多普勒检查显示4例锁骨下静脉血流正常,1例部分阻塞,1例锁骨下静脉血流完全阻塞。在最后一例中,溶栓治疗未能恢复锁骨下静脉的通畅性。搭桥移植血管通畅。7天内出现的腋-锁骨下静脉血栓形成应采用尿激酶和肝素进行局部溶栓治疗。